Related Experiment Videos

Pediatric drug therapy in the emergency department: does it meet FDA-approved prescribing guidelines?

J P McKinzie1, S W Wright, K D Wrenn

  • 1Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-4700, USA.

Insights

Pediatric emergency departments frequently deviate from Food and Drug Administration (FDA)-approved age-specific prescribing guidelines. A study found 34% of pediatric patients received medications outside these crucial pediatric drug safety guidelines.

Area of Science:

  • Pediatric Emergency Medicine
  • Pharmacology
  • Drug Safety

Background:

  • Adherence to age-specific prescribing guidelines is crucial for pediatric patient safety.
  • The Food and Drug Administration (FDA) provides age-based guidelines for medication use in children.

Purpose of the Study:

  • To assess the frequency of adherence to FDA-approved age-specific prescribing guidelines in a pediatric emergency department (ED).

Main Methods:

  • A retrospective chart review was conducted for all pediatric patients in a university hospital ED over a 30-day period.
  • Data collected included drug therapies administered in the ED and prescriptions issued upon discharge.
  • Analysis focused on comparing prescribed medications against FDA-approved age criteria.

Main Results:

  • Out of 359 children receiving drug therapy, 43% were given at least one medication not approved for their age.
  • Among 296 children discharged with prescriptions, 16% received medications outside FDA age guidelines.
  • Overall, 34% of pediatric ED patients received drug therapy not aligned with age-specific FDA guidelines.

Conclusions:

  • Drug prescribing in pediatric EDs frequently deviates from FDA-approved age-specific guidelines.
  • Bronchodilators, benzodiazepines, and narcotic analgesics were commonly prescribed outside these guidelines.
  • Improved adherence to pediatric prescribing guidelines is necessary to enhance patient safety.

Related Concept Videos